Seasonal affective disorder (SAD) and Herbal treatments

Deep Dive

From a western clinical standpoint, SAD is conceptualized as a depressive disorder with a predictable seasonal pattern—typically onset in fall/w... From a western clinical standpoint, SAD is conceptualized as a depressive disorder with a predictable seasonal pattern—typically onset in fall/winter and remission in spring—driven by reduced day length. Evidence points to circadian misalignment (phase delay or insufficient morning light), altered melatonin secretion timing, and seasonal modulation of serotonin activity. Inflammation may also vary seasonally, potentially influencing mood in susceptible individuals. First-line treatments include morning bright light therapy to correct circadian phase, cognitive-behavioral therapy tailored to SAD, and, when appropriate, antidepressants; bupropion XL has specific evidence for preventing winter recurrences. Herbal medicines are explored as adjuncts or alternatives when conventional options are insufficient, not tolerated, or declined. St. John’s wort (SJW) has robust meta-analytic support for mild-to-moderate nonseasonal depression and a plausible mechanism—primarily inhibition of serotonin, norepinephrine, and dopamine reuptake via hyperforin. Although SAD-specific randomized trials are limited, symptom overlap justifies careful adjunctive consideration. Saffron has moderate-quality RCTs demonstrating antidepressant effects versus placebo and parity with SSRIs in major depression; mechanisms include serotonergic modulation and anti-inflammatory/antioxidant actions that plausibly intersect with SAD biology. Rhodiola rosea, an adaptogen, shows early evidence for depressive symptoms and stress-related fatigue, both common in winter depression. Lemon balm, a calming herb, may ease anxiety and improve sleep quality—indirectly supporting mood in SAD. Safety is a central concern. SJW can induce hepatic enzymes and P-glycoprotein, lowering levels of many medications (e.g., oral contraceptives, anticoagulants, antiretrovirals, immunosuppressants) and carries photosensitivity and serotonin syndrome risks when combined with serotonergic drugs. Saffron may have antiplatelet effects and is contraindicated in pregnancy at medicinal doses. Rhodiola can be activating and may not be suitable for bipolar spectrum conditions. Lemon balm may potentiate sedatives. Quality and standardization vary across herbal products, complicating dose–response expectations. Clinically, herbs may be positioned as adjuncts to core SAD therapies. Realistic expectations are important: benefits, when present, often emerge over weeks, and monitoring with validated mood scales can help track response. Worsening depression, suicidal ideation, psychosis, or possible mania are urgent indications for medical assessment.